Document is current
Any future updates will be listed below
-
Authors
Tanunliong, Guadalein
Márquez, Ana Citlali
Krajden, Mel
Morshed, Muhammad
Jassem, Agatha N.
Sekirov, Inna
-
Funding
Funding for this research was provided by:
Genome BC (COV-050)
- License Information
-
More Information
Article History
Received: 11 October 2025
Accepted: 20 January 2026
First Online: 3 February 2026
Declarations
:
: Research ethics approval was obtained from the Research Ethics Board of the University of British Columbia (Approval # H20-01090) and was conducted in accordance with the public health laboratory mandate under the Public Health Act to validate SARS-CoV-2 serological assays for use in outbreak investigations and seroprevalence studies. This study was determined as minimal risk by the University’s of British Columbia Research Ethics Board (UBC REB) and requirements for informed consent were waived by the UBC REB. Not applicable, as requirement for informed consent was waived by UBC REB.
: Not applicable, as requirement for informed consent was waived by UBC REB.
: The authors declare no competing interests.
